A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

A broad proteomic analysis was conducted to identify and evaluate candidate biomarkers potentially predictive of response to treatment with an oral selective Janus kinase 1 (JAK1) inhibitor, itacitinib, in acute graft‐versus‐host disease (GVHD). Plasma samples from 25 participants (identification co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratta, Michael, Paczesny, Sophie, Socie, Gerard, Barkey, Natalie, Liu, Hao, Owens, Sherry, Arbushites, Michael C., Schroeder, Mark A., Howell, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540806/
https://www.ncbi.nlm.nih.gov/pubmed/35689489
http://dx.doi.org/10.1111/bjh.18300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540806/
https://www.ncbi.nlm.nih.gov/pubmed/35689489
http://dx.doi.org/10.1111/bjh.18300

Ejemplares similares